Login

Interview with John Lai, CEO & President of PetVivo Holdings, Inc., highlighting company insights and future plans. 00:10:00

Share On Facebook Share On Twitter

John Lai is Pres/CEO/IR/Co-Founder, Petvivo Holdings Inc.

Recent Videos

00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
00:10:00
Jim Woody on Leading 180 Life Sciences: Advancing Breakthrough Biologic Therapies for Inflammation, Fibrosis, and Pain|Dr. Jim Woody,CEO,180 Life Sciences

Suggestions

00:10:00
Blackstone Minerals talks early cashflow and partnering opportunities for Ta Khoa Project | Thomas L. Carter, CEO, Black Stone Minerals LPBSM:NYQ
00:10:00
Trailblazing Entrepreneur and ANGI Co-Founder | Angie Hicks, Co-Founder, Angi Inc.
00:10:00
Joseph Sassoon discusses the history and impact of the Sassoon family, focusing on their global trade influence and cultural evolution over generations.|Joseph Sassoon,Professor,Georgetown University
00:10:00
Exploring Color and Memory in Film History|Michael Eamon,Professor,Trent University
00:10:00
3R Petroleum: How do the company's processes work? | Matheus Dias de Siqueira, CEO, 3R Petroleum Oleo e Gas SARRRP3:SAO
00:10:00
Transforming China Merchants Bank's Global Strategy | Brian Sun, CIO, China Merchants Bank.
00:10:00
Galena Mining: Advancing the Abra Base Metals Project in Western Australia
00:10:00
higher price point just given the fact that you know you cant|Jesse Middleton,General Partner,Flybridge
00:10:00
Insights from John K. Castle at the Greenwich Economic Forum | John K. Castle, Chairman and CEO, Castle Harlan.
00:10:00
Honoring Carl Hollister: A Tribute to Dedication and Leadership
00:10:00
Stephanie Natty Olsen on We Are Rosie's Mission and the Future of Flexible Work
00:10:00
Nicholas Vickery on Patriot Lithium’s Latest Pegmatite Corridor Discovery in Black Hills | Nick Vickery ,CEO , Patriot Lithium Ltd.

© 2017 - Neuhu+